Johnson & Johnson COVID-19 vaccine use resumes in the US

Advertisements
Advertisements
Advertisements
Advertisements
Advertisements

04/26/2021 10:16 GMT —

 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) recommended on Friday that vaccination with the Johnson & Johnson COVID-19 vaccine resume in the United States.

Advertisements

A temporary pause was called 2 weeks ago to assess a number of instances of rare blood clots.

The FDA has now amended the emergency use authorization granted to this vaccine to include information about the risk of these blood clots, which mostly occurred in women aged below 50.

CDC updateTrusted Source highlights that women in this age group “should be aware of the rare but increased risk of this adverse event” and that there are alternative COVID-19 vaccines for which there are no reports of rare blood clots at this point.

“The FDA has determined that the available data show that the vaccine’s known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older,” an FDA news releaseTrusted Source states.

 

Read more about COVID-19 vaccine side effects here.

  • Credit : Medical News Today
Advertisements

Leave a Reply

Your email address will not be published. Required fields are marked *